as on September 16, 2025 at 9:39 pm IST
Day's Low
4.26%
Downside
52 Week's Low
52 Week's High
47.23%
Downside
72.51%
Upside
Check Enanta Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$177.0M
EPS (TTM)
-3.7167
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.66%
PE Ratio (TTM)
-2.39
Industry PE ratio
-3.947831325301205
P/B Ratio
0PEG Ratio
0EBITDA
-93.0M
Revenue (TTM)
64.8M
Profit Margin
-141.98%
Return On Equity TTM
5245600.00%
Track how Enanta Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.
Enanta Pharmaceuticals Inc in the last 5 years
Lowest (0.00x)
September 16, 2025
Industry (-3.95x)
September 16, 2025
Today (-2.39x)
September 16, 2025
Highest (0.00x)
September 16, 2025
Today’s Price to Earnings Ratio: -2.39x
Compare market cap, revenue, PE, and other key metrics of Enanta Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $177.0M | -84.25% | -2.39 | -141.98% | |
BUY | $61.1B | 251.26% | -505.15 | -12.96% | |
NA | $38.7B | NA | NA | -3.89% | |
BUY | $101.2B | 47.46% | 28.09 | 31.86% | |
BUY | $59.6B | 0.6% | 14.1 | 31.37% |
The Enanta Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Enanta Pharmaceuticals Inc investment value today
Current value as on today
₹70,490
Returns
Returns from Enanta Pharmaceuticals Inc Stock
Dollar Returns*
₹4,867 (+4.87%)
Based on 14 analysts
64.29%
Buy
28.57%
Hold
7.14%
Sell
Based on 14 analysts, 64.29% of analysts recommend a 'BUY' rating for Enanta Pharmaceuticals Inc. Average target price of $17.43
Get share price movements and forecasts by analysts on Enanta Pharmaceuticals Inc.
What analysts predicted
55.54%UPSIDE
Target Price
$17.43
Current Price
$7.75
Analyzed by
14 Analysts
Target
$17.43
Enanta Pharmaceuticals Inc target price $17.43, a slight upside of 55.54% compared to current price of $7.75. According to 14 analysts rating.
Search interest for Enanta Pharmaceuticals Inc Stock has decreased by -29% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 2 quarters, 14.92M → 18.31M (in $), with an average increase of 18.5% per quarter
Profit Spike
Netprofit is up for the last 2 quarters, -22.64M → -18.25M (in $), with an average increase of 24.0% per quarter
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.6% return, outperforming this stock by 107.4%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 203.1%
Price Dip
In the last 7 days, ENTA stock has moved down by -17.5%
Organisation | Enanta Pharmaceuticals Inc |
Headquarters | 4 Kingsbury Avenue, Watertown, MA, United States, 02472 |
Industry | Health Technology |
CEO | Dr. Jay R. Luly Ph.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Dr. Scott T. Rottinghaus M.D. | Chief Medical Office |
Ms. Kathleen S. Capps CPA | Interim Principal Accounting Officer |
Mr. Nathaniel S. Gardiner J.D. | Consultant |
Dr. Jay R. Luly Ph.D. | President, CEO & Director |
Mr. Matthew P. Kowalsky J.D. | Chief Legal Officer & Corporate Secretary |
Ms. Jennifer Viera | Executive Director of Investor Relations & Corporate Communications |
Ms. Tara Lynn Kieffer Ph.D. | Chief Product Strategy Officer |
Mr. Brendan Luu | Chief Business Officer |
Dr. Yat Sun Or Ph.D. | Chief Scientific Officer |
Mr. Harry R. Trout III | Interim Principal Financial Officer |
Enanta Pharmaceuticals Inc share price today is $7.75 as on . Enanta Pharmaceuticals Inc share today touched a day high of $7.75 and a low of $7.42.
Enanta Pharmaceuticals Inc share touched a 52 week high of $13.37 on and a 52 week low of $4.09 on . Enanta Pharmaceuticals Inc stock price today i.e. is trending at $7.75,which is 42.03% down from its 52 week high and 89.49% up from its 52 week low.
Enanta Pharmaceuticals Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Enanta Pharmaceuticals Inc (ENTA) shares with as little as ₹88.042 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Enanta Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Enanta Pharmaceuticals Inc share’s latest price of $7.75 as on September 16, 2025 at 9:39 pm IST, you will get 1.2903 shares of Enanta Pharmaceuticals Inc. Learn more about
fractional shares .
Enanta Pharmaceuticals Inc stock has given -84.25% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?